195 related articles for article (PubMed ID: 31927047)
1. Inhibition of lysyl oxidase ameliorates renal injury by inhibiting CD44-mediated pericyte detachment and loss of peritubular capillaries.
Saifi MA; Godugu C
Life Sci; 2020 Feb; 243():117294. PubMed ID: 31927047
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes.
Saifi MA; Shaikh AS; Kaki VR; Godugu C
J Cell Physiol; 2022 May; 237(5):2516-2527. PubMed ID: 35285015
[TBL] [Abstract][Full Text] [Related]
3. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice.
Liu SB; Ikenaga N; Peng ZW; Sverdlov DY; Greenstein A; Smith V; Schuppan D; Popov Y
FASEB J; 2016 Apr; 30(4):1599-609. PubMed ID: 26700732
[TBL] [Abstract][Full Text] [Related]
6. Targeting lysyl oxidase reduces peritoneal fibrosis.
Harlow CR; Wu X; van Deemter M; Gardiner F; Poland C; Green R; Sarvi S; Brown P; Kadler KE; Lu Y; Mason JI; Critchley HOD; Hillier SG
PLoS One; 2017; 12(8):e0183013. PubMed ID: 28800626
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by β-arrestin/ERK/STAT3 pathway.
Zhang X; Zhou W; Niu Y; Zhu S; Zhang Y; Li X; Yu C
FASEB J; 2022 Aug; 36(8):e22427. PubMed ID: 35792886
[TBL] [Abstract][Full Text] [Related]
8. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.
Martínez-Martínez E; Rodríguez C; Galán M; Miana M; Jurado-López R; Bartolomé MV; Luaces M; Islas F; Martínez-González J; López-Andrés N; Cachofeiro V
J Mol Cell Cardiol; 2016 Mar; 92():96-104. PubMed ID: 26780438
[TBL] [Abstract][Full Text] [Related]
9. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.
Kida Y; Zullo JA; Goligorsky MS
Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells transplantation attenuates renal fibrosis following acute kidney injury by repairing the peritubular capillaries.
Hu W; Li Z; Li H; Pan W; Cheng J; Zhao S; Shao Q; Liu N
Exp Cell Res; 2022 Feb; 411(1):112983. PubMed ID: 34921827
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Lysyl Oxidase with β-aminopropionitrile Improves Venous Adaptation after Arteriovenous Fistula Creation.
Hernandez DR; Applewhite B; Martinez L; Laurito T; Tabbara M; Rojas MG; Wei Y; Selman G; Knysheva M; Velazquez OC; Salman LH; Andreopoulos FM; Shiu YT; Vazquez-Padron RI
Kidney360; 2021 Feb; 2(2):270-278. PubMed ID: 34322674
[TBL] [Abstract][Full Text] [Related]
13. Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis.
Boor P; Bábíčková J; Steegh F; Hautvast P; Martin IV; Djudjaj S; Nakagawa T; Ehling J; Gremse F; Bücher E; Eriksson U; van Roeyen CR; Eitner F; Lammers T; Floege J; Peutz-Kootstra CJ; Ostendorf T
Am J Pathol; 2015 Aug; 185(8):2132-42. PubMed ID: 26216283
[TBL] [Abstract][Full Text] [Related]
14. Astaxanthin ameliorates renal interstitial fibrosis and peritubular capillary rarefaction in unilateral ureteral obstruction.
Zhao J; Meng M; Zhang J; Li L; Zhu X; Zhang L; Wang C; Gao M
Mol Med Rep; 2019 Apr; 19(4):3168-3178. PubMed ID: 30816496
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction.
Choi HY; Lee HG; Kim BS; Ahn SH; Jung A; Lee M; Lee JE; Kim HJ; Ha SK; Park HC
Stem Cell Res Ther; 2015 Mar; 6(1):18. PubMed ID: 25889661
[TBL] [Abstract][Full Text] [Related]
16. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
Annaldas S; Saifi MA; Khurana A; Godugu C
Mol Immunol; 2019 Aug; 112():247-255. PubMed ID: 31202101
[TBL] [Abstract][Full Text] [Related]
17. Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.
Gao L; Wu C; Fu F; You X; Ma X; Qin F; Li T; Wang R; Yuan J
J Cell Mol Med; 2018 Mar; 22(3):2018-2022. PubMed ID: 29278308
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Cavernosal Fibrosis and Erectile Function by Lysyl Oxidase Inhibition in a Rat Model of Cavernous Nerve Injury.
Wan ZH; Li GH; Guo YL; Li WZ; Chen L; Zhang YJ
J Sex Med; 2018 Mar; 15(3):304-313. PubMed ID: 29502979
[TBL] [Abstract][Full Text] [Related]
19. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
[TBL] [Abstract][Full Text] [Related]
20. Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women.
Craighead DH; Wang H; Santhanam L; Alexander LM
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H424-H433. PubMed ID: 29167120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
